South Korea Amniotic Membrane Market Insight
Published: 04 June 2026 | Report Format: Electronic (PDF)
The South Korean amniotic membrane Market is expected to experience an increase at a rate of 6.01% owing to rising ophthalmic procedures, increasing wound care demand, and growing regenerative medicine adoption.
South Korea Amniotic Membrane Market Insights Forecasts to 2035
- The South Korea Amniotic Membrane Market Size Was Estimated USD 96.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.01% from 2025 to 2035
- The South Korea Amniotic Membrane Market Size is Expected to rise around USD 172.78 Million by 2035
Notable Insights for the South Korea Amniotic Membrane Market
- The product-based segmentation indicates that cryopreserved amniotic membrane segment holds a commanding position with almost 56% market share in the South Korea Amniotic Membrane Market in 2025 due to increasing surgical treatment demand.
- The application-based segmentation shows that ophthalmology segment dominates with a market share of almost 62% in the South Korea Amniotic Membrane Market in 2025 owing to rising eye disorder treatment procedures.
- The global revenue for MiMedx Group, Inc. in fiscal year 2025 was estimated at about $410 million, driven by rising demand for regenerative medicine products, wound care solutions, and surgical biomaterials globally.
- As per expectations, rising regenerative medicine adoption and advanced wound care technologies will drive market expansion in which amniotic membrane solutions improve tissue healing efficiency up to 44% and recovery outcomes up to 29%.
Download the eBook (ToC)
Research Methodologies Used to Analyze the South Korea Amniotic Membrane Market
The South Korea amniotic membrane market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with healthcare providers, regenerative medicine companies, hospitals, distributors, and medical experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by governments, healthcare journals, biotechnology studies, import-export data, and industry organizations connected with regenerative medicine technologies. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Amniotic Membrane Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Amniotic Membrane Market
-
- MiMedx Group, Inc.
- Organogenesis Holdings Inc.
- Integra LifeSciences Holdings Corporation
- Applied Biologics LLC
- Celularity Inc.
- Amnio Technology, LLC
- Skye Biologics, Inc.
- TissueTech, Inc.
- Human Regenerative Technologies LLC
- Katena Products, Inc.
Recent Developments:
- In January 2026, MiMedx Group, Inc. expanded its regenerative medicine portfolio with advanced cryopreserved amniotic membrane solutions for ophthalmic and wound healing applications.
- In August 2025, Organogenesis Holdings Inc. introduced next-generation amniotic membrane products integrated with enhanced tissue preservation technologies for surgical treatment procedures.
Market Segmentation:
South Korea Amniotic Membrane Market, By Product Type
-
- Cryopreserved Amniotic Membrane
- Lyophilized Amniotic Membrane
- Dehydrated Amniotic Membrane
- Composite Amniotic Membrane
- Fresh Amniotic Membrane
South Korea Amniotic Membrane Market, By Technology
-
- Tissue Preservation Technologies
- Regenerative Medicine Solutions
- Advanced Wound Care Systems
- Biologic Tissue Engineering Technologies
- Surgical Tissue Repair Solutions
South Korea Amniotic Membrane Market, By Application
-
- Ophthalmology
- Surgical Wound Care
- Orthopedic Procedures
- Dental Applications
- Regenerative Medicine Treatments
Expert Views:
The growth of amniotic membrane market in South Korea will be facilitated by increasing regenerative medicine adoption, rising ophthalmic procedures, and growing wound care treatment demand. The use of advanced tissue preservation technologies, biologic regenerative solutions, and surgical repair systems will contribute to improved healing efficiency and enhanced demand in ophthalmology, surgical wound care, orthopedic procedures, and regenerative healthcare markets in South Korea.
Author: Govind and Krishna By Spherical Insights and Consulting